http://ir.sinica.edu.tw/handle/201000000A/88583| DC Field | Value | Language |
|---|---|---|
| dc.contributor | 生物醫學科學研究所 | - |
| dc.contributor.author | Lin, HJ | - |
| dc.contributor.author | Liang, TL | - |
| dc.contributor.author | Chang, YY | - |
| dc.contributor.author | Liu, DZ | - |
| dc.contributor.author | Fan, JY | - |
| dc.contributor.author | Roffler, SR | - |
| dc.contributor.author | Lin, SY | - |
| dc.date.accessioned | 2024-01-25T05:46:00Z | - |
| dc.date.available | 2024-01-25T05:46:00Z | - |
| dc.date.issued | 2022-06 | - |
| dc.identifier.issn | http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=1999-4923&DestApp=JCR&RQ=IF_CAT_BOXPLOT | - |
| dc.identifier.uri | http://ir.sinica.edu.tw/handle/201000000A/88583 | - |
| dc.description.sponsorship | 生物醫學科學研究所 | - |
| dc.language.iso | en | - |
| dc.relation.ispartof | Pharmaceutics 14(6), 1202 | - |
| dc.title | Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment | - |
| dc.type | journal article | - |
| dc.identifier.isi | http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=RID&SrcApp=RID&DestLinkType=FullRecord&DestApp=ALL_WOS&KeyUT=000816503100001 | - |
| dc.identifier.url | http://dx.doi.org/10.3390/pharmaceutics14061202 | - |
| dc.description.note | 已出版;[SCI];有審查制度 | - |
| item.languageiso639-1 | en | - |
| item.cerifentitytype | Publications | - |
| item.grantfulltext | none | - |
| item.openairetype | journal article | - |
| item.fulltext | no fulltext | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
| crisitem.author.dept | Institute of Biomedical Sciences | - |
| crisitem.author.parentorg | Division of Life Sciences | - |
| Appears in Collections: | 生物醫學科學研究所 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.